Zelira Therapeutics Management
Management criteria checks 3/4
Zelira Therapeutics' CEO is Oludare Odumosu, appointed in Jan 2021, has a tenure of 3.83 years. total yearly compensation is A$557.33K, comprised of 81% salary and 19% bonuses, including company stock and options. directly owns 1.16% of the company’s shares, worth $54.58K. The average tenure of the management team and the board of directors is 4.9 years and 4.9 years respectively.
Key information
Oludare Odumosu
Chief executive officer
AU$557.3k
Total compensation
| CEO salary percentage | 81.0% |
| CEO tenure | 3.8yrs |
| CEO ownership | 1.2% |
| Management average tenure | 4.9yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$557k | AU$451k | -AU$37m |
| Mar 31 2024 | n/a | n/a | -AU$36m |
| Dec 31 2023 | n/a | n/a | -AU$36m |
| Sep 30 2023 | n/a | n/a | -AU$21m |
| Jun 30 2023 | AU$479k | AU$445k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$8m |
| Dec 31 2022 | n/a | n/a | -AU$10m |
| Sep 30 2022 | n/a | n/a | -AU$11m |
| Jun 30 2022 | AU$642k | AU$449k | -AU$12m |
| Mar 31 2022 | n/a | n/a | -AU$11m |
| Dec 31 2021 | n/a | n/a | -AU$10m |
| Sep 30 2021 | n/a | n/a | -AU$9m |
| Jun 30 2021 | AU$560k | AU$318k | -AU$9m |
| Mar 31 2021 | n/a | n/a | -AU$8m |
| Dec 31 2020 | n/a | n/a | -AU$8m |
| Sep 30 2020 | n/a | n/a | -AU$8m |
| Jun 30 2020 | AU$321k | AU$114k | -AU$7m |
Compensation vs Market: Oludare's total compensation ($USD360.73K) is below average for companies of similar size in the US market ($USD646.00K).
Compensation vs Earnings: Oludare's compensation has increased whilst the company is unprofitable.
CEO
Oludare Odumosu
3.8yrs
Tenure
AU$557,327
Compensation
Dr. Oludare Odumosu serves as Director of Zelira Therapeutics Limited (formerly Zelda Therapeutics Ltd) since December 02, 2019. He serves as the Managing Director & Global Chief Executive Officer of Zelir...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | 4.9yrs | AU$151.31k | 3.78% $ 177.7k | |
| MD, Global CEO & Director | 3.8yrs | AU$557.33k | 1.16% $ 54.6k | |
| Executive Director | no data | AU$323.02k | no data | |
| Company Secretary & Non-Executive Director | 8.1yrs | AU$65.18k | 0.069% $ 3.3k | |
| Vice President of Finance & Accounting | no data | no data | no data | |
| Clinical Trial Consultant | no data | no data | no data |
4.9yrs
Average Tenure
Experienced Management: ZLDA.F's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | 4.9yrs | AU$151.31k | 3.78% $ 177.7k | |
| MD, Global CEO & Director | 4.9yrs | AU$557.33k | 1.16% $ 54.6k | |
| Executive Director | 1.8yrs | AU$323.02k | no data | |
| Company Secretary & Non-Executive Director | 2.8yrs | AU$65.18k | 0.069% $ 3.3k | |
| Member of Medical Advisory Board | no data | AU$12.00k | 2.22% $ 104.5k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 8.8yrs | no data | no data | |
| Member of Medical Advisory Board | 8.7yrs | no data | no data | |
| Scientific & Medical Advisory Board | 6.3yrs | no data | no data | |
| Scientific & Medical Advisory Board | 6.3yrs | no data | no data | |
| Independent Non-Executive Director | 1.4yrs | AU$105.76k | no data |
4.9yrs
Average Tenure
Experienced Board: ZLDA.F's board of directors are considered experienced (4.9 years average tenure).